Literature DB >> 10550887

Ibuprofen stereochemistry: double-the-trouble?

S C Tan1, B K Patel, S H Jackson, C G Swift, A J Hutt.   

Abstract

Racemic ibuprofen is an important NSAID used in the treatment of pain and inflammation in a variety of musculoskeletal and rheumatic disorders. The metabolism of ibuprofen, and that of a number of the related 2-arylpropionic acid NSAIDs, involves chiral inversion of the relatively inactive R-enantiomers to their active S-antipodes, together with other potentially stereoselective conjugative and oxidative pathways. Enantiospecific analytical methodology suitable for the determination of both the drug and its metabolites is essential in order to evaluate the significance of stereoselectivity both in terms of drug action and disposition. Recent investigations have also indicated that the R-enantiomers of these agents may not be totally devoid of useful biological activity, that the formation of acyl-coenzyme A derivatives results in interactions with lipid biochemistry, and has provided new insights into the disposition of these drugs in man. Ibuprofen represents a classical example of a drug where stereochemical considerations are essential for an understanding of its biological properties.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10550887

Source DB:  PubMed          Journal:  Enantiomer        ISSN: 1024-2430


  5 in total

1.  Inflammatory changes parallel the early stages of Alzheimer disease.

Authors:  A Parachikova; M G Agadjanyan; D H Cribbs; M Blurton-Jones; V Perreau; J Rogers; T G Beach; C W Cotman
Journal:  Neurobiol Aging       Date:  2006-10-18       Impact factor: 4.673

2.  An overview of clinical pharmacology of Ibuprofen.

Authors:  Rabia Bushra; Nousheen Aslam
Journal:  Oman Med J       Date:  2010-07

3.  Simultaneous fitting of R- and S-ibuprofen plasma concentrations after oral administration of the racemate.

Authors:  J Lötsch; U Muth-Selbach; I Tegeder; K Brune; G Geisslinger
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

4.  Stereoisomers of an Aryl Pyrazole Glucocorticoid Receptor Agonist Scaffold Elicit Differing Anti-inflammatory Responses.

Authors:  Ashley M Lato; Susan J Burke; Maggie P Ducote; Brandon J Kennedy; J Jason Collier; Shawn R Campagna
Journal:  ACS Med Chem Lett       Date:  2022-08-22       Impact factor: 4.632

Review 5.  Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility.

Authors:  Ross Cromarty; Derseree Archary
Journal:  AIDS Res Treat       Date:  2020-10-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.